Wednesday's top analyst upgrades, downgrades and initiations included Acceleron Pharma, Advanced Micro Devices, Apple, eBay, Facebook, Hasbro, 3M, Peloton, Starbucks, Tesla and Xilinx.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allstate, CalAmp, Chubb, Costco, Esperion Therapeutics, Flex, Hartford Financial Services, Nio, Rockwell Automation and...
The top analyst upgrades, downgrades and initiations seen on Friday included 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe's and Yelp.
Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.
The top analyst upgrades, downgrades and other research calls from Friday include AT&T, BlackRock, Broadcom, Diageo, Kinross Gold, United Rentals and Williams-Sonoma.
Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia.
A few biopharma stocks made massive runs over the course of this past week, some losing more than half their cap. Not all these moves were negative, but the overall sentiment was negative.
Acceleron Pharma and Celgene each saw gains on Friday after they reported results from a late-stage trial.
The top analyst upgrades, downgrades and other research calls seen on Friday include Accenture, Ally, Diageo, Harley-Davidson, KB Home, NetApp, Nike, Sirius XM and Walgreens.
Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance. The firm is cautiously optimistic on this front.
The top analyst upgrades, downgrades and other research calls from Thursday include Ardelyx, Juniper, Kroger, Phillips 66, Square, Transocean and Walmart.
A new Jefferies research report features a new list of top growth stocks to buy, and the list is dominated by top technology and biotechnology companies.
Acceleron Pharma saw its shares droop early on Tuesday after the firm offered an update from its mid-stage trial in advanced renal cell carcinoma.
The top analyst upgrades, downgrades and other research calls from Tuesday include Cheniere Energy, Consolidated Edison, Foot Locker, Shopify, Tesla, Veeco Instruments and Zoetis.
These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19, 2017 -- plus a bonus that may as well have been a downgrade to Sell.